Abstract
The role of HIV-1-specific CD4+ T-cell responses in controlling HIV-1 infection remains unclear. Previous work has suggested that such cells are eliminated in the early stages of infection in most subjects, and thus cannot substantially contribute to host defense against HIV-1. Here, using flow cytometric detection of antigen-induced intracellular cytokines, we show that significant frequencies of gag specific, T-helper-1 CD4+ memory T cells are detectable in most subjects with active/progressive HIV-1 infection (median frequency, 0.12% of memory subset; range, 0–0.66%). Median frequencies of these cells were considerably higher in nonprogressive HIV-1 disease (0.40%), but there was substantial overlap between the two groups (range of nonprogressors, 0.10–1.7%). Continuous HIV-1 suppression with anti-retroviral therapy was associated with a time-dependent reduction in median frequencies of gag-specific CD4+ memory T cells: 0.08% in subjects treated for 4–24 weeks, and 0.03% in subjects treated for 47–112 weeks. Thus, functional HIV-1-specific CD4+ T cells are commonly available for support of anti-HIV-1 effector responses in active disease, but their decline with anti-retroviral therapy indicates that immunologic participation in long-term HIV-1 control will probably require effective vaccination strategies.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Johnson, R.P., Siliciano, R.F. & McElrath, M.J. Cellular immune responses to HIV-1. AIDS 12, S113–S120 ( 1998).
Ferbas, J. Perspectives on the role of CD8+ cell suppressor factors and cytotoxic T lymphocytes during HIV infection. AIDS Res. Hum. Retroviruses 14, S153–S160 ( 1998).
Steinman, R.M. & Germain, R.N. Antigen presentation and related immunological aspects of HIV-1 vaccines. AIDS 12, S97–S112 (1998).
Ogg, G.S. et al. Quantitation of HIV-1 - Specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 279, 2103 –2106 (1998).
Matano, T. et al. Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques. J. Virol. 72 , 164–169, 1998.
Levy, J.A. Pathogenesis of human immunodeficiency virus infection. Microbiol. Rev. 57, 183–289 ( 1993).
Valentine, F.T., Palino, A., Saito, A. & Holzman, R.S. Lymphocyte-proliferative responses to HIV antigens as a potential measure of immunological reconstituion in HIV disease. AIDS Res. Hum. Retroviruses 14, S161–S166 (1998).
Rosenberg, E.S. & Walker, B.D. HIV type 1-specific helper T cells: A critical host defense. AIDS Res. Hum. Retroviruses 14, S143–S147 ( 1998).
Moss, R.B. et al. A primer on HIV type 1-specific immune function and remuneTM. AIDS Res. Hum. Retroviruses 14, S167–S175 (1998).
Schwartz, D. et al. Absence of recoverable infectious virus and unique immune responses in an asymptomatic HIV+ long-term survivor. AIDS Res. Hum. Retroviruses 10, 1703–1711 (1994).
Rosenberg, E.S. et al. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science 278, 1447–1450 (1997).
Groux, H. et al. Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals. J. Exp. Med. 175:331–340 ( 1992).
Cottrez, F. et al. Priming of human CD4+ antigen-specific T cells to undergo apoptosis by HIV-infected monocytes. J. Clin. Invest. 99, 257–266 (1997).
Clerici, M. et al., Antigen-stimulated apoptotic T-cell death in HIV infection is selective for CD4+ T cells, modulated by cytokines and effected by lymphotoxin. AIDS 10, 603–611 (1996).
Romieu, R., Baratin, M., Kayibanda, M., Guillet J-G . & Viguier, M. IFN—-secreting Th cells regulate both the frequency and avidity of epitope-specific CD8+ T lymphocytes induced by peptide immunization: an ex vivo analysis. Int. Immunol. 10, 1273– 1270 (1998).
Matloubian, M., Concepcion, R.J. & Ahmed, R. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J. Virol. 68, 8056–8063 (1994).
Battegay, M. et al. Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice. J. Viro. 68, 4700 –4704 (1994).
von Herrath, M.G., Yokoyama, M., Dockter, J., Oldstone, M.B.A. & Whitton, J.L. CD4- deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge. J. Virol. 70, 1072–1079 (1996).
Cardin, R.D., Brooks, J.W. & Sarawar, S.R., Progressive loss of CD8+ T cell-mediated control of a γ-Herpesvirus in the absence of CD4+ T cells. J. Exp. Med. 184, 863–871 ( 1996).
Walter, E.A. et al. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T cell clones from the donor. N. Engl. J. Med. 333, 1038– 1044 (1995).
Waldrop, S.L., Pitcher, C.J., Peterson, D.M., Maino, V.C. & Picker, L.J. Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry. J. Clin. Invest. 99, 1739–1750 ( 1997).
Waldrop, S.L., Davis, K.A., Maino V.C. & Picker L.J. Normal human CD4+ memory T cells display broad heterogeneity in their activation threshold for cytokine synthesis, J. Immunol. 161, 5284 –5295 (1998).
Komanduri, K. V. et al. Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1. Nature Med. 4, 953– 956 (1998).
Haase, A.T. Population biology of HIV-1 infection: Vital and CD4+ T cell demographics and dynamics in lymphatic tissues. Annu. Rev. Immunol. 17, 625–656 (1999).
Cavert, W. et al. Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science 276, 960–964 (1997).
Callahan, K.M., Fort, M.M., Obah, E.A., Reinherz, E.L. & Siliciano, R.F., Genetic variability in HIV-1 gp120 affects interactions with HLA molecules and T cell receptor. J. Immunol. 144, 3341–3346 (1990).
Harcourt, G.C., Garrand, S., Davenport, M.P., Edwards, A. & Phillips, R.E. HIV-1 variation diminishes CD4 T lymphocyte recognition. J. Exp. Med. 188, 1785–1794 (1998).
Butcher, E.C. & Picker, L.J. Lymphocyte homing and homeostasis. Science 272, 60–66 (1996).
Andersson, J. et al. Early reduction of immune activation in lymphoid tissue following highly active HIV therapy. AIDS 12, F123 –F129 (1998).
Hellerstein, M. et al. Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans. Nature Med. 5, 83–89 (1999).
Gorochev, G. et al. Perturbation of CD4+ and CD8+ T cell repertoires during progression to AIDS and reulation of the CD4+ repertoire during antiviral therapy. Nature Med. 4, 215–221 ( 1998).
Mackall, C.L. & Gress, R.E. Pathways of T-cell regeneration in mice and humans: implications for bone marrow transplantation and immunotherapy. Immunol. Rev. 157, 61– 72 (1997).
Wong, J.K. et al. Recovery of replication-competent HIV despite suppression plasma viremia. Science 278, 1291– 1295 (1997).
Collins, R.H. Jr. et al. Immune reconstitution with donor–derived memory/effector T cells after orthotopic liver transplantation, Exp. Hematol. 25, 147–159 (1997).
Acknowledgements
We thank D. Douek and R. McFarland for critical review of the manuscript, D. Ambrosak and Fred Scott for technical assistance, W. Frawley for statistical analysis, R. Moss, P. Valenzuela, and G. Naciemento for provision of antigen preparations, B. Dawson for viral load determinations, and R. Barber and P. Keiser for assistance with subject recruitment. This work was supported by NIH grants AI31545 (L.J.P) and AI35522 (R.A.K), a grant from the Texas Higher Education Coordinating Board (L.J.P.), and the UT Southwestern AIDS Clinical Research Fund (D.M.P.). R.A.K. is an Elizabeth Glaser Scientist of the Pediatric AIDS Foundation.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pitcher, C., Quittner, C., Peterson, D. et al. HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression . Nat Med 5, 518–525 (1999). https://doi.org/10.1038/8400
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/8400
This article is cited by
-
Immunogenicity of personalized dendritic-cell therapy in HIV-1 infected individuals under suppressive antiretroviral treatment: interim analysis from a phase II clinical trial
AIDS Research and Therapy (2022)
-
The forces driving clonal expansion of the HIV-1 latent reservoir
Virology Journal (2020)
-
Preserved immune functionality and high CMV-specific T-cell responses in HIV-infected individuals with poor CD4+ T-cell immune recovery
Scientific Reports (2017)
-
Survivin-specific CD4+ T cells are decreased in patients with survivin-positive myeloma
Journal for Immunotherapy of Cancer (2015)
-
The impact of differential antiviral immunity in children and adults
Nature Reviews Immunology (2012)